Working with TipRanks
Follow Us
Stocks
ETFs
Options
Commodities
Crypto
Currency
Pro Newsletters
Research Tools
Calendars
Economic Indicators
Calculators
Education
About Us
Working with TipRanks
Follow Us
Sarepta Therapeutics (GB:0L35)
LSE:0L35
Holding GB:0L35?
Track your performance easily
| Jun 24 | Mar 24 | Dec 23 | Sep 23 | Jun 23 | |
|---|---|---|---|---|---|
| Income Statement | - | ||||
| Total Revenue | $ 362.93M | $ 413.46M | $ 396.78M | $ 331.82M | $ 261.24M |
| Gross Profit | $ 362.93M | $ 413.46M | $ 547.12M | $ 331.82M | $ 239.00M |
| EBIT | $ 18.76M | $ 96.17M | $ 45.60M | $ -27.95M | $ -9.36M |
| EBITDA | $ 27.48M | $ 104.92M | $ 56.98M | $ -17.02M | $ 1.43M |
| Net Income Common Stockholders | $ 6.46M | $ 36.12M | $ 45.66M | $ 8.42M | $ -23.94M |
| Balance Sheet | - | ||||
| Cash, Cash Equivalents and Short-Term Investments | $ 1.46B | $ 1.39B | $ 1.68B | $ 1.73B | $ 1.86B |
| Total Assets | $ 3.42B | $ 3.22B | $ 3.26B | $ 3.11B | $ 3.13B |
| Total Debt | $ 1.37B | $ 1.38B | $ 1.40B | $ 1.37B | $ 1.36B |
| Net Debt | $ -90.61M | $ -11.44M | $ -279.39M | $ -362.02M | $ -496.04M |
| Total Liabilities | $ 2.35B | $ 2.26B | $ 2.41B | $ 2.35B | $ 2.38B |
| Stockholders Equity | $ 1.08B | $ 961.19M | $ 859.34M | $ 764.36M | $ 741.41M |
| Cash Flow | - | ||||
| Free Cash Flow | $ -14.22M | $ -284.52M | $ -73.70M | $ -155.62M | $ -38.14M |
| Operating Cash Flow | $ 14.94M | $ -242.08M | $ -54.66M | $ -114.71M | $ -122.23M |
| Investing Cash Flow | $ -98.53M | $ 218.80M | $ -64.36M | $ -210.57M | $ 96.63M |
| Financing Cash Flow | $ 39.92M | $ 22.14M | $ 1.94M | $ 15.40M | $ 5.86M |